ADHD, Cocaine Dependence, Cognition Disorders
Conditions
Keywords
Repetitive Transcranial Magnetic Stimulation, Cocaine Dependence, Cocaine Addicts, Attention Deficit Hyperactivity Disorder, Cognitive Function
Brief summary
Even in the absence of a preliminary diagnosis of Attention Deficit Hyperactivity Disorder, symptoms of attention deficit, hyperactivity and cognitive impairment are common in cocaine addicts. Several factors indicate that repetitive transcranial magnetic stimulation might be a strategy to aid in the treatment of symptoms of attention deficit hyperactivity disorder and cognitive function in cocaine addicts. However, up to current days there have been no studies evaluating the effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on neurocognitive performance of individuals suffering from the ADHD.
Detailed description
Transcranial Magnetic Stimulation is a noninvasive technique that can influence specific areas of the brain and has very few side effects. The treatment with transcranial magnetic stimulation requires attendance to hospital daily sessions for 4 consecutive weeks. Each session lasts up to 30 minutes. Side effects include scalp discomfort and mild headache. No anesthesia is required. Stimulation aims the dorsolateral prefrontal cortex, a region previously studied to treat depression symptoms with positive results. The present technique has never been employed in previous studies, but risks are insignificant.
Interventions
OTHERrepetitive Transcranial Magnetic Stimulation (rTMS)
20 daily sessions: each with 25 trains of 10 seconds at 5Hz, with a 20 second inter-train interval, at an intensity of 120% of motor threshold. Site: Left Dorsolateral Prefrontal Cortex
Sponsors
University of Sao Paulo General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
No
Inclusion criteria
* Cocaine Dependence Syndrome (alone or in combination with alcohol and/or nicotine dependence with symptoms of ADHD, according to the criteria of the DSM-IV-R (APA, 2000), as well as through a structured clinical interview (SCID-1/P v 2.0) * Minimum age of 18 * Maximum age of 40 * 20 days or less abstinence. * any psychopharmacological treatment other than clonazepam (4 mg/day)
Exclusion criteria
* Metallic Cerebral Implant * Pacemakers * History of Severe Brain trauma or injury * Organic Brain Disease * Previous neurosurgery * History of seizures * Epilepsy * Severe Somatic Disease * History of other actual or past psychiatric diagnostics * Clinically significant changes in laboratory test * Any psychiatric or neurological disorder other than Cocaine Dependence with symptoms of ADHD * Psychotic depression * Suicidal propensities
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Wender Utah Rating Scale (WURS) - Diagnostic Criteries ADHD (DSM IV) | 4 weeks | Scales to assess attention deficit hyperactivity disorder symptoms will be applied at pre-treatment (T0) and post treatment - week 4 (T1). Reduction on the scores of WURS and synptoms of ADHD diagnostic (as on the scores of Barrat Impulsiviness Scale - BIS 11 and Minnesota Cocaine Craving Scale - MCCS; and improves Hamilton Depressive Rating Scale - HDRS 17 and Hamilton Anxiety Rating Scale - HARS 14). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Battery of Neuropsychological Tests | 4 weeks | Cognitive performance battery will be applied at pre-treatment (T0) and post treatment - week 4 (T1). Performance of neuropsychological tests - Trail Making Test; Wisconsin Card Sorting Test; Controlled Oral Word Association Test; Victoria Stroop Test; Rey Auditory Verbal Learning Test; WAIS-III (adapted for use in Brazil) subtests Cubes, Vocabulary, Digit Span; Wechsler Logical Memory and Iowa Gambling Task (IGT). |
Countries
Brazil
Contacts
Primary ContactDebora Arnaut, PSYD
Outcome results
None listed